Back

Disparities in the access to atrial fibrillation ablation in Denmark

1 September 2024 (11:00 - 11:30)
Organised by: Logo
Congress Presentation Part of: Rhythm control for atrial fibrillation: procedures and outcomes Catheter Ablation of Arrhythmias ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Christopher Ryan Zoerner

Herlev and Gentofte Hospital, Copenhagen (Denmark)

5 More presentations in this session

Presentation thumbnail
Same-day discharge after atrial fibrillation ablation: is it equally safe?
Doctor A. Abrantes (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Transoesophageal echocardiography-guided cardioversion and thromboembolism.
Doctor M. Lunden (Norrkoping, SE)
Abstract Slides Video
Presentation thumbnail
Comparison of complications during catheter ablation of atrial fibrillation between radiofrequency and cryoballoon ablation: insights from a nation-wide claims-based database
Doctor K. Miyamoto (Suita, JP)
Abstract Slides Video
Presentation thumbnail
Long-term efficacy and safety of ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy
Doctor A. Wang Gottlieb (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Procedural findings and follow-up results of catheter ablation of atrial fibrillation in patients after radiation therapy for breast cancer
Doctor M. Tydecks (Munich, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Rhythm control for atrial fibrillation: procedures and outcomes

The Event

Event poster

ESC Congress 2024

1 September 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Percutaneous ablation in patients with atrial fibrillation: presentation of the general situation in the region with special focus on Kazakhstan
thumbnail
Congress Presentation
Exploring the impact of catheter ablation on health care resource utilisation of atrial fibrillation patients
thumbnail
Congress Presentation
Care and outcomes of atrial fibrillation in potentially vulnerable populations: A 20-year perspective using real-world data

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources